These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2498457)

  • 41. Low-density lipoproteins inhibit the Na+/H+ antiport in human platelets. A novel mechanism enhancing platelet activity in hypercholesterolemia.
    Nofer JR; Tepel M; Kehrel B; Wierwille S; Walter M; Seedorf U; Zidek W; Assmann G
    Circulation; 1997 Mar; 95(6):1370-7. PubMed ID: 9118502
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dual effect of lovastatin and simvastatin on LDL-macrophage interaction.
    Aviram M; Keidar S; Brook GJ
    Eur J Clin Chem Clin Biochem; 1991 Oct; 29(10):657-64. PubMed ID: 1764540
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Etofibrate increases binding of low and high density lipoprotein to human platelets of patients with type II hyperlipoproteinemia.
    Virgolini I; Koller E; Li S; Yang Q; Banyai M; Rauscha F; Pidlich J; Pirker W; Sinzinger H
    Atherosclerosis; 1993 Sep; 102(2):217-26. PubMed ID: 8251008
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modification of protein moiety of human low density lipoprotein by hypochlorite generates strong platelet agonist.
    Volf I; Bielek E; Moeslinger T; Koller F; Koller E
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):2011-8. PubMed ID: 10938025
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pravastatin inhibits cellular cholesterol synthesis and increases low density lipoprotein receptor activity in macrophages: in vitro and in vivo studies.
    Keidar S; Aviram M; Maor I; Oiknine J; Brook JG
    Br J Clin Pharmacol; 1994 Dec; 38(6):513-9. PubMed ID: 7888289
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of (E)-4-hydroxy-2-nonenal in platelet activation by low density lipoprotein and iron.
    Selley ML; Bartlett MR; Czeti AL; Ardlie NG
    Atherosclerosis; 1998 Sep; 140(1):105-12. PubMed ID: 9733221
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intracellular mechanisms in the activation of human platelets by low-density lipoproteins.
    Andrews HE; Aitken JW; Hassall DG; Skinner VO; Bruckdorfer KR
    Biochem J; 1987 Mar; 242(2):559-64. PubMed ID: 3109394
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevention of cholesteryl ester accumulation in P388D1 macrophage-like cells by increased cellular vitamin E depends on species of extracellular cholesterol. Conventional heterologous non-human cell cultures are poor models of human atherosclerotic foam cell formation.
    Asmis R; Llorente VC; Gey KF
    Eur J Biochem; 1995 Oct; 233(1):171-8. PubMed ID: 7588742
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extracts of human atherosclerotic lesions can modify low density lipoproteins leading to enhanced uptake by macrophages.
    Hoff HF; O'Neil J
    Atherosclerosis; 1988 Mar; 70(1-2):29-41. PubMed ID: 3355615
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of murine macrophage growth by modified LDLs.
    Yui S; Sasaki T; Miyazaki A; Horiuchi S; Yamazaki M
    Arterioscler Thromb; 1993 Mar; 13(3):331-7. PubMed ID: 8443137
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Macrophage uptake of oxidized LDL inhibits lysosomal sphingomyelinase, thus causing the accumulation of unesterified cholesterol-sphingomyelin-rich particles in the lysosomes. A possible role for 7-Ketocholesterol.
    Maor I; Mandel H; Aviram M
    Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1378-87. PubMed ID: 7670952
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhanced macrophage degradation of biologically modified low density lipoprotein.
    Henriksen T; Mahoney EM; Steinberg D
    Arteriosclerosis; 1983; 3(2):149-59. PubMed ID: 6838433
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of lycopene on the induction of foam cell formation by modified LDL.
    Napolitano M; De Pascale C; Wheeler-Jones C; Botham KM; Bravo E
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1820-7. PubMed ID: 17911344
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cholesterol or triglyceride loading of human monocyte-derived macrophages by incubation with modified lipoproteins does not induce tissue factor expression.
    van den Eijnden MM; van Noort JT; Hollaar L; van der Laarse A; Bertina RM
    Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):384-92. PubMed ID: 9974423
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oxidized LDL increase free cholesterol and fail to stimulate cholesterol esterification in murine macrophages.
    Roma P; Catapano AL; Bertulli SM; Varesi L; Fumagalli R; Bernini F
    Biochem Biophys Res Commun; 1990 Aug; 171(1):123-31. PubMed ID: 2393386
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Large and cholesteryl ester-rich high-density lipoproteins in cholesteryl ester transfer protein (CETP) deficiency can not protect macrophages from cholesterol accumulation induced by acetylated low-density lipoproteins.
    Ishigami M; Yamashita S; Sakai N; Arai T; Hirano K; Hiraoka H; Kameda-Takemura K; Matsuzawa Y
    J Biochem; 1994 Aug; 116(2):257-62. PubMed ID: 7822240
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma lipoproteins affect platelet malondialdehyde and thromboxane B2 production.
    Aviram M; Sirtori CR; Colli S; Maderna P; Morazzoni G; Tremoli E
    Biochem Med; 1985 Aug; 34(1):29-36. PubMed ID: 4052061
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Platelet-enhanced apolipoprotein E production by human macrophages: a possible role in atherosclerosis.
    Takagi Y; Dyer CA; Curtiss LK
    J Lipid Res; 1988 Jul; 29(7):859-67. PubMed ID: 3411246
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Platelet-modified lipoprotein induced by thrombin: effect of whole blood and plasma.
    Aviram M; Maor I; Rosenblat M; Dankner G; Brook JG
    Isr J Med Sci; 1988; 24(4-5):193-200. PubMed ID: 3378876
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acetylated low density lipoprotein inhibits the incorporation of arachidonic acid in phospholipids with a concomitant increase of cholesterol arachidonate in rat peritoneal macrophages.
    Pollaud C; Krause S; Lepert JC; Orfila C; Séguélas M; Festal D; Decerprit J; Pipy B
    Biochim Biophys Acta; 1995 Dec; 1259(3):211-9. PubMed ID: 8541327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.